Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
305 |
|
| Actual shortage: | 10 (3%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 5 (2%) | |
| Resolved: | 288 (94%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
48 (16%) |
|
Overdue reports |
3 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ADENOSINE INJECTION | 3MG | SOLUTION | Actual shortage | 2024-03-19 | 2024-04-01 | 222725 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2mg/mL | Solution | Resolved | 2018-06-06 | 2018-10-02 | 51677 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2 mg/mL | Solution | Resolved | 2018-06-06 | 2018-10-02 | 51680 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 5 mg/mL | Solution | Resolved | 2018-06-06 | 2019-09-13 | 51683 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10 mg/mL | Solution | Resolved | 2018-06-06 | 2019-03-01 | 51686 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10 mg/mL | Solution | Resolved | 2018-06-06 | 2019-03-01 | 51691 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2019-07-26 | 2020-01-16 | 90057 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-04-07 | 2020-04-25 | 111239 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-12-09 | 2021-01-22 | 129882 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2021-03-26 | 2022-01-31 | 136445 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2021-03-26 | 2022-04-13 | 136448 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Avoided shortage | 2022-04-13 | 2022-07-15 | 158783 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2022-04-13 | 2022-07-15 | 158786 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-03-26 | 2021-04-16 | 136455 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-03-26 | 2021-04-16 | 136460 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-10-21 | 2021-12-31 | 147731 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-04-13 | 2022-09-01 | 158789 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-04-13 | 2022-08-29 | 158792 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-01-16 | 2023-04-04 | 181154 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-01-16 | 2023-11-17 | 181157 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0